NCT07295600 Postprandial Effect of Isocaloric Challenge Meals Enriched With Indigenous Fruits and Vegetables on Glucose Metabolism in Individuals With Type 2 Diabetes in Wakiso District, Uganda
| NCT ID | NCT07295600 |
| Status | Recruiting |
| Phase | — |
| Sponsor | KU Leuven |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 8 participants |
| Start Date | 2026-05-18 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 8 participants in total. It began in 2026-05-18 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate changes in glucose and lipid levels after consuming challenge meals enriched with selected indigenous fruits and vegetables in people living with type 2 diabetes in Wakiso district. The main question to answer is: Does the consumption of challenge meals enriched with indigenous fruits and vegetables improve glucose and lipid levels among people living with type 2 diabetes? Researchers will compare the effects of different challenge meals on glucose and lipid levels to identify the indigenous fruit and vegetable with the strongest glucose- and lipid-lowering effects. Participants will: Consume five challenge meals over 5 weeks. Visit the study site after a 5-7 day rest period to consume the challenge meal and complete the tests.
Eligibility Criteria
Inclusion Criteria: * Fasting blood sugar \>= \[7 mmol/L\](based on medical records) * Diabetic regimen for at least 6 months * Type 2 diabetes * Plans to continue staying in the same location for the next 6 months Exclusion Criteria: * Taking dietary supplements * Type 1 diabetes * Tuberculosis co-infection * Renal failure * Liver cirrhosis * Chronic pancreatitis * Pregnancy and Lactation * Regular sports activity * Parallel participation in another clinical trial * On treatment for dyslipidaemia, * On treatment for hypertension * Very low blood pressure (\< 90/50 mmHg) * Allergic reactions to test products
Contact & Investigator
Christophe Matthys, Phd
PRINCIPAL INVESTIGATOR
KU Leuven University, Belgium
Frequently Asked Questions
Who can join the NCT07295600 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 60 Years, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07295600 currently recruiting?
Yes, NCT07295600 is actively recruiting participants. Contact the research team at tonny.kiyimba1@gmail.com for enrollment information.
Where is the NCT07295600 trial being conducted?
This trial is being conducted at Wakiso, Uganda.
Who is sponsoring the NCT07295600 clinical trial?
NCT07295600 is sponsored by KU Leuven. The principal investigator is Christophe Matthys, Phd at KU Leuven University, Belgium. The trial plans to enroll 8 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.